Abstract:Inflammatory bowel disease (IBD) increases the risk of colorectal cancer, and it has the potential to diminish the quality of life. Clinical and experimental evidence demonstrate protective aspects of parasitic helminth infection against IBD. However, studies on the inhibition of inflammation by helminth infection have overlooked a key determinant of health: the gut microbiota. Although infection with helminths induces alterations in the host microbiota composition, the potential influence and mechanism of helminth infections induced changes in the gut microbiota on the development of IBD has not yet been elucidated. In this study, we analyzed the intersection of helminth Trichinella spiralis and gut bacteria in the regulation of colitis and related mechanisms. T . spiralis infected mice were treated with antibiotics or cohoused with wild type mice, then challenged with dextran sodium sulfate (DSS)-colitis and disease severity, immune responses and goblet cells assessed. Gut bacteria composition was assessed by 16S rRNA sequencing and short-chain fatty acids (SCFAs) were measured. We found that protection against disease by infection with T . spiralis was abrogated by antibiotic treatment, and cohousing with T . spiralis - infected mice suppressed DSS-colitis in wild type mice. Bacterial community profiling revealed an increase in the abundance of the bacterial genus Muribaculum and unclassified_Muribaculaceae in mice with T . spiralis infection or mice cohoused with T . spiralis - infected mice. Metabolomic analysis demonstrated significantly increased propionic acid in feces from T . spiralis - infected mice. Data also showed that the gut microbiome modulated by T . spiralis exhibited enhanced goblet cell differentiation and elevated IL-10 levels in mice. These findings identify the gut microbiome as a critical component of the anti- colitic effect of T . spiralis and gives beneficial insights into the processes by which helminth alleviates colitis. IBD encompasses Crohn's Disease and Ulcerative Colitis. It affects both children and adults. Reports have highlighted the potential use of helminths or their byproducts as a possible treatment for IBD. Accumulating evidence also suggests that the gut microbiota is a key factor in modulating IBD. In this study, we revealed the protective effect of a prior infection with T . spiralis on DSS- induced colitis in mice. Specifically, T . spiralis infection reshaped the gut microbiome of mice, resulting in an increased abundance of SCFA-producing bacteria Muribaculum and unclassified_Muribaculaceae and thereby producing a larger amount of propionic acid. Furthermore, the gut microbiome modulated by T . spiralis exhibited enhanced goblet cell differentiation and elevated IL-10 levels, ultimately ameliorating experimental colitis. These findings suggest that the modulation of host microbiota during T . spiralis infection plays a crucial role in the suppression of colitis, and any intention-to-treat with helminth therapy should be based on the patient's immunological and microbiological response to the helminth.

Toll-like Receptor Activation by Helminths or Helminth Products to Alleviate Inflammatory Bowel Disease

Helminth Infections and Intestinal Inflammation

[Effect of Toll-like Receptors on Helminth Infection].

Anti-cytokine Therapy and Small Molecule Agents for the Treatment of Inflammatory Bowel Disease

The gut microbiota is essential for - evoked suppression of colitis

The gut microbiota is essential for Trichinella spiralis —Evoked suppression of colitis

Helminth-derived metabolites induce tolerogenic functional, metabolic, and transcriptional signatures in dendritic cells that attenuate experimental colitis

Cooperation between host immunity and the gut bacteria is essential for helminth-evoked suppression of colitis

Fecal microbiota transplantation alleviates experimental colitis through the Toll-like receptor 4 signaling pathway

Modulation of inflammation by toll-like receptor 4/nuclear factor-kappa B in diarrhea-predominant irritable bowel syndrome

Interaction between tissue-dwelling helminth and the gut microbiota drives mucosal immunoregulation

Intestinal helminth skews DC2 development towards regulatory phenotype to counter the anti-helminth immune response

Immune Regulation by helminth parasites: cellular and molecular mechanisms

Trichinella spiralis: inflammation modulator.

Toll-like receptor signaling in parasitic infections

Trichinella- derived protein ameliorates colitis by altering the gut microbiome and improving intestinal barrier function

Interactions between toll-like receptors signaling pathway and gut microbiota in host homeostasis

Helminth-derived proteins as immune system regulators: a systematic review of their promise in alleviating colitis

Helminth products modulate innate immune recognition of nucleic acids in systemic lupus erythematosus

The influence of intestinal dysbacteriosis on visceral sensitivity and possible mechanisms

The Negative Correlation Study of Parasitic Infection and Inflammatory Bowel Disease